2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$48.34+$0.35 (+0.73%)
Price as of Aug 03, 2026 4:39 AM EDT- $4.7BMarket Cap
- -14.44%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$48.34+$0.35 (+0.73%)
CRSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $47.99 | ||
Change | -$0.45 (-0.93%) | ||
Open | $48.54 | ||
High | $49.03 | ||
Low | $47.31 | ||
Previous Close | $48.44 | ||
Volume | 1,036,271 | ||
30-Day Average Volume | 1,700,077 | ||
1-Week Change | 3.12% | ||
1-Month Change | -12.01% | ||
1-Year Change | -14.44% | ||
3-Year Change | -16.29% | ||
5-Year Change | -60.35% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $2.7B | ||
Market Cap | $4.7B | ||
Enterprise Value | $4.9B | ||
Period: QTR TTM FY | |||
Revenue | $1.0M | ||
Net Income | -$122.9M | ||
Free Cash Flow | -$109.4M | ||
EBIT | -$121.5M | ||
EBITDA | -$117.2M | ||
Net Working Capital | $2.3B | ||
EPS | -$1.28 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | 4,894 | ||
P/B | 3 | ||
P/E | -37 | ||
PEG | -6 | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue